Project Grant HT94252510681
Award Date
7/15/25
Completion Date
7/14/28
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
The $309,086 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the Centre for Eye Research Australia Limited (operating as the University of Melbourne Department of Ophthalmology) to target NADPH oxidase 4 to reduce ocular scarring following chemical burns to the eye. The project will run from July 2025 to June 2027 and aims to develop innovative medical treatments to address this critical eye...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
This $426,400 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Chicago to conduct nanoscale structural and molecular mapping of the optic nervous system following ocular blast. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing understanding of the impact of ocular blast injuries on the nervous system. The award...
The University of Illinois has been awarded a $1,465,443 federal Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420). The funding will support advanced biomedical research focused on the "Promise of Epigenetic Therapy for Refractory Testicular Germ Cell Tumors" over a 3-year period from September 1, 2025 to August 31, 2028. The Military Medical Research and Development program provides funding for innovative medical...
The Schepens Eye Research Institute, Inc. was awarded a $1,475,676 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop concomitant topical treatments for pain and inflammation resulting from ocular injuries. The Military Medical Research and Development program supports biomedical research that transforms military and public health...
The Defense Health Agency awarded a $1,407,585 cooperative agreement to The Washington University under the Military Medical Research and Development program (CFDA 12.420) from September 30, 2022 to September 29, 2026. The award will support research to validate an ELISPOT assay for identifying immunosuppression and infection in critically ill burn patients, and determine if the assay can predict sepsis early in serious burn injury. A subaward of $XXX,XXX was provided to the Coalition For...
The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
The Defense Health Agency awarded a $1,466,706 Project Grant to The Schepens Eye Research Institute, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective September 1, 2025 through August 31, 2028, will fund research on "Topical Oxygen for Pan-Ocular Protection (TOPP) Against Severe Chemical Injury". The Schepens Eye Research Institute, a non-profit organization affiliated with Harvard Medical School, will conduct preclinical and...
The Defense Health Agency awarded a $1,061,440 Project Grant to the University of South Florida (USF) on September 1, 2023 under the Military Medical Research and Development (CFDA 12.420) program. This 3-year grant will support USF's development of an artificial cornea and sensor-based continuous intraocular pressure (IOP) monitoring system to treat patients with cornea blindness secondary to war-related ocular injuries. The products and services to be delivered through this grant include...